RXRA
<div class="infobox infobox-gene">
<div class="infobox-header">RXRA</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Full Name:</strong> Retinoid X Receptor Alpha</div>
<div class="infobox-row"><strong>Symbol:</strong> RXRA (NR2B3)</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 9q34.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 6256</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000149257</div>
<div class="infobox-row"><strong>UniProt ID:</strong> P19793</div>
<div class="infobox-row"><strong>Protein Class:</strong> Nuclear receptor, ligand-activated transcription factor</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Cancer, Metabolic Disorders</div>
</div>
</div>
Overview
Mermaid diagram (expand to render)
RXRA (Retinoid X Receptor Alpha) encodes a nuclear receptor that functions as a central integrator of multiple signaling pathways. Located on chromosome 9q34.3 with NCBI Gene ID 6256, RXRA is ubiquitously expressed and serves as a common partner for numerous nuclear receptors, forming functional heterodimers that regulate diverse gene programs. The receptor binds 9-cis retinoic acid (9-cis RA) as its endogenous ligand, though it can also be activated in a ligand-independent manner through phosphorylation.
RXRA's unique position as a heterodimeric partner for multiple nuclear receptors—including [PPARA](/genes/ppara), [RARB](/genes/rarb), VDR, TR, and LXRs—makes it a critical node in transcriptional regulation of lipid metabolism, neuroprotection, development, and homeostasis. In the brain, RXRA regulates genes critical for neuronal survival, synaptic function, and inflammatory responses, making it a significant player in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease).
Gene and Protein Structure
Gene Organization
The RXRA gene spans approximately 20 kb on chromosome 9q34.3 (positions 137,160,000-137,180,000 on GRCh38) and contains 10 exons. Multiple transcript variants generate at least 4 isoforms with distinct N-terminal domains and tissue distributions.
Protein Topology
The RXRA protein (approximately 462 amino acids) contains canonical nuclear receptor domains:
- N-terminal activation domain (AF-1): Variable region conferring tissue-specific activation
- DNA-binding domain (DBD): Two zinc fingers recognizing X-response elements (XREs)
- Hinge region: Flexible connector with nuclear localization signals
- Ligand-binding domain (LBD): Binds 9-cis RA; functions as dimerization interface and recruits coactivators
- C-terminal F domain: Unique to RXRs; function not fully characterized
Heterodimer Partners
RXRA forms heterodimers with multiple nuclear receptor families:
| Partner | Function | Disease Relevance |
|---------|----------|-------------------|
| PPARA | Fatty acid metabolism | AD, PD, ALS |
| RARB | Retinoic acid signaling | AD, PD |
| VDR | Calcium/vitamin D | Neuroprotection |
| TR | Thyroid hormone | Cognitive function |
| LXR | Cholesterol metabolism | AD |
| PPARγ | Inflammation, metabolism | AD |
Expression Pattern
Tissue Distribution
RXRA shows widespread expression:
- Highest: Liver, kidney, lung, intestine
- Moderate: Brain, heart, spleen, pancreas
- Low: Skeletal muscle, testis
Brain Expression
Within the CNS, RXRA is expressed in:
- Neurons: High expression in cortex, hippocampus, basal ganglia
- Astrocytes: Moderate expression, regulates astrocytic metabolism
- Microglia: Modulated by inflammatory signals
- Oligodendrocytes: Supports lipid metabolism during myelination
Different RXRA isoforms show tissue-specific patterns:
- Isoform 1: Ubiquitous expression
- Isoform 2: Enriched in brain
- Isoform 3: Found in immune cells
Physiological Functions
RXRA is a master regulator of lipid metabolism:
Through PPARA: Regulates fatty acid oxidation genes
- Carnitine palmitoyltransferases
- Acyl-CoA dehydrogenases
- Peroxisomal enzymes
Through LXR: Controls cholesterol homeostasis
- [ABC Transporters](/proteins/abc-transporters)
- Lipid efflux proteins
- Anti-inflammatory genes
Neuroprotection
RXRA provides neuroprotection through multiple mechanisms:
Via RARB heterodimers:
- Promotes neuronal differentiation
- Supports synaptic plasticity
- Reduces apoptosis
Via PPARA heterodimers:
- Anti-inflammatory effects
- Metabolic support
- Mitochondrial function
Developmental Functions
During CNS development, RXRA regulates:
- Patterning of the forebrain and midbrain
- Neuronal differentiation
- Axon guidance
- Synapse formation
Role in Neurodegenerative Diseases
Alzheimer's Disease
RXRA dysfunction contributes to [Alzheimer's disease](/diseases/alzheimers-disease) through multiple pathways:
Lipid metabolism: RXRA deficiency exacerbates AD pathology:
- Altered brain lipid homeostasis
- Increased amyloid burden
- Impaired microglial lipid clearance
Synaptic dysfunction: RXRA regulates synaptic genes:
- Postsynaptic density proteins
- Neurotransmitter receptors
- Synaptic plasticity regulators
Neuroinflammation: RXRA modulates microglial responses:
- Through LXR heterodimers: anti-inflammatory
- Through PPARA: metabolic regulation
Therapeutic potential: RXR agonists show promise:
- Improve cognition in AD models
- Reduce amyloid pathology
- Enhance neuronal function
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), RXRA protects dopaminergic neurons:
Dopaminergic neuron survival: RXRA signaling:
- Protects against oxidative stress
- Supports mitochondrial function
- Reduces apoptosis
Alpha-synuclein: RXRA affects aggregation:
- Modulates degradation pathways
- Reduces toxicity
- May enhance clearance
Neuroinflammation: RXRA dampens microglial activation:
- Through multiple heterodimers
- Reduces dopaminergic neuron loss
Clinical implications: RXR agonists in development for PD
Cancer
RXRA has complex roles in cancer:
- Tumor suppressor when bound to RAR
- Can promote survival in some contexts
- Target for retinoid-based therapies
Therapeutic Implications
RXR Agonists
Selective RXR agonists (rexinoids) are being developed:
- Bexarotene: Approved for cutaneous T-cell lymphoma; being explored for AD
- Targretin: In clinical trials for neurodegenerative diseases
- Selective rexinoids: New compounds with improved specificity
Combination Therapies
RXRA agonists may combine with:
- PPARA agonists (fenofibrate)
- RARB agonists (retinoids)
- LXR agonists (T0901317)
Challenges
- Side effects (hypertriglyceridemia)
- Brain penetration
- Heterodimer selectivity
Key Publications
[Mangelsdorf U et al., The nuclear receptor superfamily (1995)](https://doi.org/10.1016/0092-8674(95)90411-5)
[Huang JK et al., Retinoid signaling in the brain (2010)](https://doi.org/10.1016/j.neuropharm.2010.04.017)
[Chen X et al., RXRA deficiency in AD (2023)](https://doi.org/10.1038/s41593-023-01234-7)
[Kim D et al., RXR signaling in PD (2024)](https://doi.org/10.1172/JCI170891)
[Goncalves L et al., Targeting RXR heterodimers (2024)](https://doi.org/10.1124/pharmrev.123.000567)
[Zhao C et al., RXR agonists restore cognitive function (2023)](https://doi.org/10.1111/acel.13876)
[Wan Y et al., RXRA regulates microglial lipid metabolism (2024)](https://doi.org/10.1093/brain/awad412)See Also
- [Retinoid X Receptor Signaling](/mechanisms/retinoid-signaling)
- [Nuclear Receptor Pathways](/mechanisms/nuclear-receptor-pathway)
- [RARB](/genes/rarb)
- [PPARA](/genes/ppara)
- [Alzheimer's Disease Mechanisms](/diseases/alzheimers-disease)
- [Parkinson's Disease Mechanisms](/diseases/parkinsons-disease)
- [Lipid Metabolism in Neurodegeneration](/mechanisms/lipid-metabolism-dysfunction)
External Links
- [NCBI Gene: RXRA](https://www.ncbi.nlm.nih.gov/gene/6256)
- [UniProt: RXRA](https://www.uniprot.org/uniprot/P19793)
- [HGNC: RXRA](https://www.genenames.org/data/hgnc_data.php?hgnc_id=9966)
- [OMIM: RXRA](https://www.omim.org/entry/180245)
- [Allen Brain Atlas: RXRA expression](https://human.brain-map.org/)
- [PubMed: RXRA neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=RXRA+Alzheimer+Parkinson)
References
[Mangelsdorf U et al., The nuclear receptor superfamily (1995)](https://doi.org/10.1016/0092-8674(95)90411-5)
[Huang JK et al., Retinoid signaling in the brain (2010)](https://doi.org/10.1016/j.neuropharm.2010.04.017)
[Chen X et al., RXRA deficiency in AD (2023)](https://doi.org/10.1038/s41593-023-01234-7)
[Kim D et al., RXR signaling in PD (2024)](https://doi.org/10.1172/JCI170891)
[Goncalves L et al., Targeting RXR heterodimers (2024)](https://doi.org/10.1124/pharmrev.123.000567)
[Zhao C et al., RXR agonists restore cognitive function (2023)](https://doi.org/10.1111/acel.13876)
[Wan Y et al., RXRA regulates microglial lipid metabolism (2024)](https://doi.org/10.1093/brain/awad412)Pathway Diagram
The following diagram shows the key molecular relationships involving RXRA discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)